These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus. Steiner G Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087 [TBL] [Abstract][Full Text] [Related]
26. Cardiovascular risk in women with polycystic ovary syndrome. Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960 [TBL] [Abstract][Full Text] [Related]
27. The metabolic syndrome and cardiovascular disease: part 2. Jiamsripong P; Mookadam M; Alharthi MS; Khandheria BK; Mookadam F Prev Cardiol; 2008; 11(4):223-9. PubMed ID: 19476575 [TBL] [Abstract][Full Text] [Related]
28. The role of adiponectin in obesity, diabetes, and cardiovascular disease. Kawano J; Arora R J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516 [TBL] [Abstract][Full Text] [Related]
29. The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms. Gans RO Med Clin North Am; 2006 Jul; 90(4):573-91. PubMed ID: 16843763 [TBL] [Abstract][Full Text] [Related]
30. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Gaspard U Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194 [TBL] [Abstract][Full Text] [Related]
31. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome? Corbould A Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851 [TBL] [Abstract][Full Text] [Related]
32. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. Alexander CJ; Tangchitnob EP; Lepor NE Rev Cardiovasc Med; 2009; 10(2):83-90. PubMed ID: 19593320 [TBL] [Abstract][Full Text] [Related]
33. The cardiometabolic syndrome in the adolescent. Gardner M; Gardner DW; Sowers JR Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711 [TBL] [Abstract][Full Text] [Related]
34. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Sarafidis PA Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384 [TBL] [Abstract][Full Text] [Related]
35. Insulin Resistance and the cardiometabolic syndrome in HIV infection. Bevilacqua M; Dominguez LJ; Barbagallo M J Cardiometab Syndr; 2009; 4(1):40-3. PubMed ID: 19245515 [TBL] [Abstract][Full Text] [Related]
38. Chromium in metabolic and cardiovascular disease. Hummel M; Standl E; Schnell O Horm Metab Res; 2007 Oct; 39(10):743-51. PubMed ID: 17952838 [TBL] [Abstract][Full Text] [Related]
39. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498 [TBL] [Abstract][Full Text] [Related]
40. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Ren J; Kelley RO Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]